632 related articles for article (PubMed ID: 32980358)
1. Eclampsia in the 21st century.
Fishel Bartal M; Sibai BM
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1237-S1253. PubMed ID: 32980358
[TBL] [Abstract][Full Text] [Related]
2. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, prevention, and management of eclampsia.
Sibai BM
Obstet Gynecol; 2005 Feb; 105(2):402-10. PubMed ID: 15684172
[TBL] [Abstract][Full Text] [Related]
4. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
[TBL] [Abstract][Full Text] [Related]
5. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
[TBL] [Abstract][Full Text] [Related]
6. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study.
Dröge LA; Perschel FH; Stütz N; Gafron A; Frank L; Busjahn A; Henrich W; Verlohren S
Hypertension; 2021 Feb; 77(2):461-471. PubMed ID: 33280406
[TBL] [Abstract][Full Text] [Related]
8. Preeclampsia diagnosis and management.
Overton E; Tobes D; Lee A
Best Pract Res Clin Anaesthesiol; 2022 May; 36(1):107-121. PubMed ID: 35659948
[TBL] [Abstract][Full Text] [Related]
9. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
11. Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management.
Maged AM; Elsherief A; Hassan H; Salaheldin D; Omran KA; Almohamady M; Dahab S; Fahmy R; AbdelHak A; Shoab AY; Lotfy R; Lasheen YS; Nabil H; Elbaradie SMY
J Matern Fetal Neonatal Med; 2020 Jan; 33(2):314-321. PubMed ID: 29914278
[No Abstract] [Full Text] [Related]
12. Cerebral biomarkers in neurologic complications of preeclampsia.
Bergman L; Hastie R; Bokström-Rees E; Zetterberg H; Blennow K; Schell S; Imberg H; Langenegger E; Moodley A; Walker S; Tong S; Cluver C
Am J Obstet Gynecol; 2022 Aug; 227(2):298.e1-298.e10. PubMed ID: 35257666
[TBL] [Abstract][Full Text] [Related]
13. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
Rana S; Burke SD; Karumanchi SA
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
[TBL] [Abstract][Full Text] [Related]
14. Fetal heart rate tracings associated with eclamptic seizures.
Ambia AM; Wells CE; Yule CS; McIntire DD; Cunningham FG
Am J Obstet Gynecol; 2022 Oct; 227(4):622.e1-622.e6. PubMed ID: 35662632
[TBL] [Abstract][Full Text] [Related]
15. Prediction of imminent preeclampsia at 35-37 weeks gestation.
Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
[TBL] [Abstract][Full Text] [Related]
16. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
[TBL] [Abstract][Full Text] [Related]
17. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
18. Incidence of eclampsia and related complications across 10 low- and middle-resource geographical regions: Secondary analysis of a cluster randomised controlled trial.
Vousden N; Lawley E; Seed PT; Gidiri MF; Goudar S; Sandall J; Chappell LC; Shennan AH;
PLoS Med; 2019 Mar; 16(3):e1002775. PubMed ID: 30925157
[TBL] [Abstract][Full Text] [Related]
19. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
20. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
